Autologous Hematopoietic Stem Cell Transplantation Combined With CAR-T Cells in the Treatment of Refractory and Relapsed Malignant Lymphoma

NCT05239676 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

UNKNOWN

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Lymphoma

Interventions

BIOLOGICAL: Autologous hematopoietic stem cell transplantation combined with CD19 CAR-T cells

Sponsor

Zhejiang University

Collaborators

[object Object]